3.70000 EUR
0.02
0.54%
Last update Dec 15, 8:12 AM CET
Main market
Day range
3.70000
3.70000
Previous close
3.72000
Open
3.70000
Access this stock data via API
Subscribe
Knight Therapeutics Inc.
3.70
0.02
0.54%

Overview

Access /time_series data via our API — starting from the Basic plan.

Description

Knight Therapeutics Inc. is a Canadian-based specialty pharmaceutical company. Its core purpose is to develop, acquire, license, and deliver innovative pharmaceutical products to fulfill unmet medical needs. The company places a strong emphasis on the therapeutic fields of oncology, infectious diseases, and select consumer health products. Utilizing strategic partnerships, in-licensing, and acquisitions, Knight Therapeutics bolsters its product portfolio with high-potential medications that meet rigorous regulatory standards. Operating largely across Canada and Latin America, it plays a crucial role in enhancing healthcare outcomes within these geographies. The company is noteworthy for its commitment to sustainable growth and value creation in the pharmaceutical industry, and its adaptability in responding to market demands and healthcare trends solidifies its standing as a key player in the regional pharmaceutical landscape.

About

CEO
Ms. Samira Sakhia BCom, CA, CPA, MBA
Employees
745
Address
3400 de Maisonneuve Blvd. W.
Suite 1055
Montreal, H3Z 3B8, QC
Canada
Phone
514-484-4483
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Germany
MIC code
XDUS
Access /profile data via our API — starting from the Grow plan.
Main market

Exchange is currently active.
Closing in 8 hours 48 minutes

11:11
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).